Miltenyi Biotec is a global leader in developing technologies that empower biomedical research and personalized medicine, drawing on 35 years of expertise across more than 60 scientific disciplines. The company specializes in cell isolation, sorting, and sample preparation, providing essential tools for immunology, stem cell, cancer, and neuroscience research, as well as molecular analysis and clinical applications. With a portfolio that includes antibodies, cytokines, imaging agents, and advanced tissue dissociation techniques, Miltenyi Biotec supports both basic and translational science worldwide. Its distinctive advantage lies in a creative, pioneering culture that unites over 4,700 experts from more than 50 countries, enabling continuous innovation and the translation of cutting‑edge science into real‑world medical solutions.
We are seeking a highly motivated Scientist to join our Experimental Process Development group supporting the establishment of viral delivery platforms that enable next generation cell and gene therapies. In this entry level downstream development role, the incumbent will contribute to the development, optimization, and characterization of novel purification processes for lentiviral vectors (LVVs) to support research, process development, and GMP aligned manufacturing activities.
Miltenyi Biotec is a global leader in developing technologies that empower biomedical research and personalized medicine, drawing on 35 years of expertise across more than 60 scientific disciplines. The company specializes in cell isolation, sorting, and sample preparation, providing essential tools for immunology, stem cell, cancer, and neuroscience research, as well as molecular analysis and clinical applications. With a portfolio that includes antibodies, cytokines, imaging agents, and advanced tissue dissociation techniques, Miltenyi Biotec supports both basic and translational science worldwide. Its distinctive advantage lies in a creative, pioneering culture that unites over 4,700 experts from more than 50 countries, enabling continuous innovation and the translation of cutting‑edge science into real‑world medical solutions.
Globalchannelmanagement